Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
HIV Medicine|December 31, 2021
The National Evaluation of Malawi's PMTCT Program (NEMAPP) study: 24-month HIV-exposed infant outcomes from a prospective cohort studyMonique van Lettow, Beth A Tippett Barr, Joep J van Oosterhout, et al.Journal of the International AIDS Society|August 4, 2017
Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goalsMargaret L Prust, Clement K Banda, Rose Nyirenda, et al.Global Public Health|June 2, 2020
Implications of HIV treatment policies on the health workforce in rural Malawi and Tanzania between 2013 and 2017: Evidence from the SHAPE-UTT studyJohn Songo, Alison Wringe, Farida Hassan, et al.Plos Medicine|May 30, 2019
The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settingsPeter D Ehrenkranz, Solange L Baptiste, Helen Bygrave, et al.Tropical Medicine and Infectious Disease|June 2, 2021
Assessing the Impact of COVID-19 on TB and HIV Programme Services in Selected Health Facilities in Lilongwe, Malawi: Operational Research in Real TimePruthu Thekkur, Hannock Tweya, Sam Phiri, et al.The Lancet. HIV|November 24, 2018
National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysisBeth A Tippett Barr, Monique van Lettow, Joep J van Oosterhout, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2017
Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of TanzaniaThokozani Kalua, Beth A Tippett Barr, Joep J van Oosterhout, et al.AIDS (London, England)|June 26, 2021
Incidence of HIV-positive admission and inpatient mortality in Malawi (2012-2019)Rachael M Burke, Marc Y R Henrion, Jane Mallewa, et al.The Lancet. HIV|July 29, 2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort studyBirgit Schramm, Elvis Temfack, Diane Descamps, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
A Patient-Centered, Combination Intervention to Support Adherence to HIV Pre-exposure Prophylaxis During Pregnancy and Breastfeeding: A Randomized Pilot Study in MalawiBenjamin H Chi, Friday Saidi, Lauren A Graybill, et al.Pageof 5